WRBC
RENE

W.R. Berkley Corp’s Cartesian Growth Corp II RENE Stock Holding History

W.R. Berkley Corp’s Portfolio RENE Stock Details RENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,080,913
Closed -$12.9M – 261
2025
Q2 		$12.9M Buy
1,080,913
+472,733
+78% +$5.63M 0.68% 31
2025
Q1 		$7.22M Hold
608,180
– – 0.42% 37
2024
Q4 		$7.09M Sell
608,180
-458,115
-43% -$5.3M 0.28% 46
2024
Q3 		$12.2M Sell
1,066,295
-340,105
-24% -$3.87M 0.69% 34
2024
Q2 		$15.9M Buy
1,406,400
+128,947
+10% +$1.45M 0.67% 33
2024
Q1 		$14.2M Buy
1,277,453
+255,545
+25% +$2.82M 0.79% 32
2023
Q4 		$11.2M Buy
1,021,908
+696,009
+214% +$7.57M 0.81% 18
2023
Q3 		$3.52M Buy
325,899
+77,224
+31% +$828K 0.23% 67
2023
Q2 		$2.65M Buy
+248,675
New +$2.63M 0.16% 93

Other funds holding RENE

CA
Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return

W.R. Berkley Corp's RENE Position: Q3 2025 in Review

W.R. Berkley Corp sold out of Cartesian Growth Corp II (RENE) in Q3 2025, closing a stake of 1,080,913 shares — an estimated $12.9M sold.

W.R. Berkley Corp first reported a position in RENE in Q2 2023 and held it in 9 quarters. The position peaked at $15.9M in Q2 2024. 1 fund tracked by Wall St. Rank holds RENE as of Q3 2025.

  • W.R. Berkley Corp reported no remaining Cartesian Growth Corp II position as of Q3 2025 after selling out during the quarter.
  • W.R. Berkley Corp sold 1,080,913 Cartesian Growth Corp II shares in Q3 2025, an estimated $12.9M.
  • W.R. Berkley Corp first reported a position in Cartesian Growth Corp II in Q2 2023 and held it in 9 quarters.
  • W.R. Berkley Corp's Cartesian Growth Corp II position peaked at $15.9M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Cartesian Growth Corp II as of Q3 2025.

Based on W.R. Berkley Corp's 13F filing for Q3 2025, filed 14 Nov 2025.